ApprovalTrail

Drug · DIN 00869945

PROSTIGMIN

Authorized, but not sold for a year or more

Authorized, but the company reports it has not been sold in Canada for at least 12 months.

Status Dormant since January 14, 2022; first marketed December 31, 1988.
Drug Identification Number (DIN)
00869945
Company (DIN owner)
Bausch Health, Canada Inc.Laval, Quebec, Canada
Schedule
Prescription
Dosage form
Tablet
Route
Oral
Therapeutic class (ATC)
Neostigmine N07AA01
Class
Human
Record last updated
February 23, 2026

Active ingredients

As listed in the Drug Product Database.

IngredientStrengthPer
NEOSTIGMINE BROMIDE15 MG